October Pharma

Last Updated:
  • 104.20 EGP
  • -4.94
  • -4.53%
اكتوبر فارما ش م م
اكتوبر فارما
Symbol : OCPH
ISIN : EGS380R1C018
Day Range : -
Turnover Ratio : 0.02
Market : Egyptian Exchange
Sector : Health Care & Pharmaceuticals
Latest Announcements
2024-11-14 07:28:00.0العنوان : اكتوبر فارما (OCPH.CA) القوائم الماليةاسم الشركة : اكتوبر فارماكود الترقيم الدولي : EGS380R1C018كود رويترز : OCPH.CAمضمو
2024-11-14 07:26:00.0October Pharma (OCPH.CA) - Board of Directors' Decision
2024-10-13 12:06:00.0October Pharma (OCPH.CA) - Disclosure Form Concerning the BoD & the Shareholders' Structure
2024-10-13 12:03:00.0Correction from October Pharma (OCPH.CA) Regarding Company’s Disclosure Report Form
2024-10-08 12:05:00.0Release from October Pharma (OCPH.CA) Regarding the Published On One of the Newspapers

October Pharma SAE Stock Overview

View Company Profile

Stock Summary

Last Price (EGP) 104.20
Prev. Close 109.140
Day Range 101.00 - 104.24
52WK range
Turnover (M EGP) 0.10
Volume (M) 0.00
Number of Trades 24
Market Cap (M EGP) 1,212.00
Change in Market Cap (M EGP)
VWAP (EGP) 0.00
EPS (TTM) --
EX-Dividend Date
Dividend
Dividend Yield (%)
Beta
30D Avg Volume
30D Avg Turnover(M EGP)
Outstanding Shares
Free Float Shares
Free Float %

Stock Performance

Stock Highlights

Highest Market Cap
Date of Highest Mkt. Cap
Lowest Market Cap
Date of Lowest Mkt. Cap
View Advanced Chart

Earnings Progress

Date Provider Title Category File
Date Provider Title Category File
  • No Upcoming Events

Cairo – Mubasher: The board of October Pharma approved the estimated budget for 2022, expecting a net profit after tax worth EGP 135 million by the...

Cairo – Mubasher: October Pharma achieved a 65% year-on-year (YoY) increase in its net profits, logging EGP 100.32 million in the first nine...

Cairo – Mubasher: October Pharma recorded a surge of 402% in net profits to EGP 40.59 million during the first quarter (Q1) of 2021, compared to...

Cairo – Mubasher: The ordinary general meeting (OGM) of October Pharma approved a cash dividend of 30% of the capital or EGP 3 per share for 2020.The...

Cairo – Mubasher: October Pharma’s net profits for the year 2020 leapt by 161% on an annual basis, driven by lower production costs and expenses,...